Melissa D. Cooper

HIV Treatment Optimization
05/21/2014
Tampa—Medicaid is the largest payer of HIV care in the United States, covering about 4 in 10 patients with HIV. According to estimates, Medicaid spends $5.3 billion on HIV prevention and treatment, with prescription drugs as the largest...
Tampa—Medicaid is the largest payer of HIV care in the United States, covering about 4 in 10 patients with HIV. According to estimates, Medicaid spends $5.3 billion on HIV prevention and treatment, with prescription drugs as the largest...
Tampa—Medicaid is the largest...
05/21/2014
First Report Managed Care
Conference Insider
Idiopathic Pulmonary Fibrosis Treatment Option
06/10/2015
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease in which the tissue in the lungs hardens causing a progressive decline in lung function. IPF typically occurs in Caucasian males ≥50 years of age who have a history of...
Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease in which the tissue in the lungs hardens causing a progressive decline in lung function. IPF typically occurs in Caucasian males ≥50 years of age who have a history of...
Idiopathic pulmonary fibrosis...
06/10/2015
First Report Managed Care
News
Effect of Medicare Part D and Generics on Breast Cancer Treatment
06/18/2015
In the United States, breast cancer is the second most common cancer diagnosis and the second most fatal form of cancer among women. Endocrine therapy agents, including aromatase inhibitors (AIs) and tamoxi- fen, have shown effectiveness in...
In the United States, breast cancer is the second most common cancer diagnosis and the second most fatal form of cancer among women. Endocrine therapy agents, including aromatase inhibitors (AIs) and tamoxi- fen, have shown effectiveness in...
In the United States, breast...
06/18/2015
First Report Managed Care
ACE and ARB Treatment among Medicare Beneficiaries with Diabetes and Hypertension
04/22/2014
Between 2000 and 2010, the percentage of patients aged ≥65 years with diabetes and hypertension increased from 9% to 15%. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) have proven to decrease the...
Between 2000 and 2010, the percentage of patients aged ≥65 years with diabetes and hypertension increased from 9% to 15%. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs) have proven to decrease the...
Between 2000 and 2010, the...
04/22/2014
First Report Managed Care
Conference Insider
Cost Savings in the Specialty Medical Benefit
06/10/2015
In 2014, only 1% of US prescriptions were specialty drugs, but they represented 31.8% of drug spend. This was a 27.7% increase from 2013, and specialty drug utilization in both the medical benefit and pharmacy benefit markets is expected to...
In 2014, only 1% of US prescriptions were specialty drugs, but they represented 31.8% of drug spend. This was a 27.7% increase from 2013, and specialty drug utilization in both the medical benefit and pharmacy benefit markets is expected to...
In 2014, only 1% of US...
06/10/2015
First Report Managed Care
News
Treatment Option for Moderate-to-Severe Plaque Psoriasis
06/10/2015
Approximately 2.2% of the US population has psoriasis, making it the most common autoimmune disease in the United States. This disease greatly impacts quality of life, especially the lives of those diagnosed with moderate-to- severe...
Approximately 2.2% of the US population has psoriasis, making it the most common autoimmune disease in the United States. This disease greatly impacts quality of life, especially the lives of those diagnosed with moderate-to- severe...
Approximately 2.2% of the US...
06/10/2015
First Report Managed Care
Beta-Carotene and Vitamin E Not Recommended for Cancer and CVD Prevention
04/22/2014
Between 2007 and 2010, 49% of adults in the United States reported using at least 1 dietary supplement and 32% reported using a multivitamin-multimineral supplement. In 2011, cancer and cardiovascular disease (CVD) were accountable for 22.8%...
Between 2007 and 2010, 49% of adults in the United States reported using at least 1 dietary supplement and 32% reported using a multivitamin-multimineral supplement. In 2011, cancer and cardiovascular disease (CVD) were accountable for 22.8%...
Between 2007 and 2010, 49% of...
04/22/2014
First Report Managed Care
Conference Insider
Risks Associated with Statin Therapy
01/20/2015
While statins have been successful in lowering low-density lipoprotein cholesterol, there are also overlooked risks.
While statins have been successful in lowering low-density lipoprotein cholesterol, there are also overlooked risks.
While statins have been...
01/20/2015
First Report Managed Care
Weight Management in Diabetes Patients
01/20/2015
Weight management is crucial to successfully managing diabetes. 
Weight management is crucial to successfully managing diabetes. 
Weight management is crucial to...
01/20/2015
First Report Managed Care
Obstacles for PCPs Prescribing Buprenorphine for Opioid Addiction
04/22/2014
Although buprenorphine is the only available drug for office-based physicians for the treatment of opioid addiction that reports high rates of prolonged success, a recent study found 11 of 17 Oregon primary care physicians (PCPs) trained to...
Although buprenorphine is the only available drug for office-based physicians for the treatment of opioid addiction that reports high rates of prolonged success, a recent study found 11 of 17 Oregon primary care physicians (PCPs) trained to...
Although buprenorphine is the...
04/22/2014
First Report Managed Care

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use